questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Maladies de la moelle osseuse
Maladies de la moelle osseuse : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Biopsie de la moelle osseuse
Anémie
Leucémie
Aspirations de moelle osseuse
Tests génétiques
Hématologie
Fatigue
Infections
Saignements
Imagerie par résonance magnétique
Tomodensitométrie
Moelle osseuse
Tests sanguins
Anomalies sanguines
Hématologie
Symptômes
5
Fatigue
Fièvre
Douleurs osseuses
Système immunitaire
Globules blancs
Immunodéficience
Saignements
Plaquettes
Hémorragie
Douleurs osseuses
Infiltration
Cellules anormales
Types de maladies
Symptômes
Hématologie
Prévention
5
Prévention
Mode de vie sain
Hérédité
Facteurs de risque
Produits chimiques
Toxiques
Alimentation
Santé
Moelle osseuse
Tabagisme
Facteurs de risque
Maladies hématologiques
Examens réguliers
Prévention
Anomalies
Traitements
5
Chimiothérapie
Radiothérapie
Greffe de moelle osseuse
Greffe de moelle osseuse
Efficacité
Risques
Médicaments
Immunosuppresseurs
Facteurs de croissance
Radiothérapie
Cancer
Moelle osseuse
Traitements personnalisés
Type de maladie
Gravité
Complications
5
Complications
Infections
Insuffisance médullaire
Cancer
Risque
Maladies de la moelle osseuse
Infections
Immunodéficience
Moelle osseuse
Saignements
Plaquettes
Graves
Insuffisance médullaire
Anémie
Hémorragies
Facteurs de risque
5
Facteurs de risque
Radiations
Antécédents familiaux
Âge
Risque
Maladies de la moelle
Maladies auto-immunes
Risque
Moelle osseuse
Mode de vie
Tabagisme
Risque
Infections virales
VIH
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies de la moelle osseuse : Questions médicales les plus fréquentes",
"headline": "Maladies de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-15",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aplasies médullaires",
"alternateName": "Bone Marrow Failure Disorders",
"url": "https://questionsmedicales.fr/mesh/D000080983",
"about": {
"@type": "MedicalCondition",
"name": "Aplasies médullaires",
"code": {
"@type": "MedicalCode",
"code": "D000080983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie aplasique",
"alternateName": "Anemia, Aplastic",
"url": "https://questionsmedicales.fr/mesh/D000741",
"about": {
"@type": "MedicalCondition",
"name": "Anémie aplasique",
"code": {
"@type": "MedicalCode",
"code": "D000741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"alternateName": "Myelodysplastic-Myeloproliferative Diseases",
"url": "https://questionsmedicales.fr/mesh/D054437",
"about": {
"@type": "MedicalCondition",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"code": {
"@type": "MedicalCode",
"code": "D054437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Leucémie myélomonocytaire juvénile",
"alternateName": "Leukemia, Myelomonocytic, Juvenile",
"url": "https://questionsmedicales.fr/mesh/D054429",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie myélomonocytaire juvénile",
"code": {
"@type": "MedicalCode",
"code": "D054429",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615.520"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myélodysplasiques",
"alternateName": "Myelodysplastic Syndromes",
"url": "https://questionsmedicales.fr/mesh/D009190",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myélodysplasiques",
"code": {
"@type": "MedicalCode",
"code": "D009190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire",
"alternateName": "Anemia, Refractory",
"url": "https://questionsmedicales.fr/mesh/D000753",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire",
"code": {
"@type": "MedicalCode",
"code": "D000753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anémie sidéroblastique",
"alternateName": "Anemia, Sideroblastic",
"url": "https://questionsmedicales.fr/mesh/D000756",
"about": {
"@type": "MedicalCondition",
"name": "Anémie sidéroblastique",
"code": {
"@type": "MedicalCode",
"code": "D000756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.070"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hémoglobinurie paroxystique",
"alternateName": "Hemoglobinuria, Paroxysmal",
"url": "https://questionsmedicales.fr/mesh/D006457",
"about": {
"@type": "MedicalCondition",
"name": "Hémoglobinurie paroxystique",
"code": {
"@type": "MedicalCode",
"code": "D006457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.460"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myéloprolifératifs",
"alternateName": "Myeloproliferative Disorders",
"url": "https://questionsmedicales.fr/mesh/D009196",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myéloprolifératifs",
"code": {
"@type": "MedicalCode",
"code": "D009196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie myélophtisique",
"alternateName": "Anemia, Myelophthisic",
"url": "https://questionsmedicales.fr/mesh/D000750",
"about": {
"@type": "MedicalCondition",
"name": "Anémie myélophtisique",
"code": {
"@type": "MedicalCode",
"code": "D000750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.085"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucémie érythroblastique aigüe",
"alternateName": "Leukemia, Erythroblastic, Acute",
"url": "https://questionsmedicales.fr/mesh/D004915",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie érythroblastique aigüe",
"code": {
"@type": "MedicalCode",
"code": "D004915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myélofibrose primitive",
"alternateName": "Primary Myelofibrosis",
"url": "https://questionsmedicales.fr/mesh/D055728",
"about": {
"@type": "MedicalCondition",
"name": "Myélofibrose primitive",
"code": {
"@type": "MedicalCode",
"code": "D055728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.765"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytose",
"alternateName": "Thrombocytosis",
"url": "https://questionsmedicales.fr/mesh/D013922",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytose",
"code": {
"@type": "MedicalCode",
"code": "D013922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.860"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse",
"alternateName": "Bone Marrow Diseases",
"code": {
"@type": "MedicalCode",
"code": "D001855",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sebastian Berg",
"url": "https://questionsmedicales.fr/author/Sebastian%20Berg",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Charlotte Niemeyer",
"url": "https://questionsmedicales.fr/author/Charlotte%20Niemeyer",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Ioannis Mitroulis",
"url": "https://questionsmedicales.fr/author/Ioannis%20Mitroulis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
},
{
"@type": "Person",
"name": "George Hajishengallis",
"url": "https://questionsmedicales.fr/author/George%20Hajishengallis",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.)."
}
},
{
"@type": "Person",
"name": "Triantafyllos Chavakis",
"url": "https://questionsmedicales.fr/author/Triantafyllos%20Chavakis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Placenta Accreta Spectrum.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005229"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiology and Pathophysiology of the Placenta.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39403751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2024.39.e271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de la moelle osseuse",
"item": "https://questionsmedicales.fr/mesh/D001855"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies de la moelle osseuse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies de la moelle osseuse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies de la moelle osseuse",
"description": "Comment diagnostiquer une maladie de la moelle osseuse ?\nQuels tests sont utilisés pour évaluer la moelle osseuse ?\nQuels signes indiquent une maladie de la moelle osseuse ?\nQuelle imagerie est utilisée pour la moelle osseuse ?\nLes tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies de la moelle osseuse",
"description": "Quels sont les symptômes courants des maladies de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle le système immunitaire ?\nLes maladies de la moelle osseuse causent-elles des saignements ?\nPeut-on avoir des douleurs osseuses avec ces maladies ?\nLes symptômes varient-ils selon le type de maladie ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies de la moelle osseuse",
"description": "Peut-on prévenir les maladies de la moelle osseuse ?\nQuels facteurs de risque sont évitables ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les maladies de la moelle ?\nLes examens réguliers aident-ils à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies de la moelle osseuse",
"description": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?\nLa greffe de moelle osseuse est-elle efficace ?\nQuels médicaments sont utilisés pour traiter ces maladies ?\nLa radiothérapie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies de la moelle osseuse",
"description": "Quelles complications peuvent survenir avec ces maladies ?\nLes maladies de la moelle osseuse augmentent-elles le risque de cancer ?\nComment les infections sont-elles liées à ces maladies ?\nLes saignements peuvent-ils être graves ?\nQuelles sont les conséquences d'une insuffisance médullaire ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies de la moelle osseuse",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de maladies de la moelle ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie peut-il affecter le risque ?\nLes infections virales sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Placenta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de la moelle osseuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des analyses sanguines, biopsies et examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la moelle osseuse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'aspiration de moelle osseuse et des tests génétiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie de la moelle osseuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent fatigue, infections fréquentes et saignements anormaux."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour la moelle osseuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et la tomodensitométrie sont souvent utilisées pour visualiser la moelle."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent révéler des anomalies dans les cellules sanguines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies de la moelle osseuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, ecchymoses et douleurs osseuses."
}
},
{
"@type": "Question",
"name": "Comment la moelle osseuse affecte-t-elle le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse malade peut réduire la production de globules blancs, affaiblissant l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des saignements excessifs en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs osseuses avec ces maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs osseuses peuvent survenir en raison de l'infiltration de cellules anormales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de maladie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de maladie de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies de la moelle osseuse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies sont héréditaires, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des produits chimiques toxiques peut réduire le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé de la moelle osseuse et du sang."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les maladies de la moelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs maladies hématologiques."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse."
}
},
{
"@type": "Question",
"name": "La greffe de moelle osseuse est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être curative pour certaines maladies, mais comporte des risques."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter ces maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agents immunosuppresseurs et les facteurs de croissance sont utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour traiter certaines formes de cancer de la moelle."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction du type et de la gravité de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces maladies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, saignements et insuffisance médullaire."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies de la moelle osseuse peuvent augmenter le risque de cancers secondaires."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées à ces maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse défaillante peut entraîner une immunodéficience, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les saignements peuvent-ils être graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements graves peuvent survenir en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une insuffisance médullaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuffisance médullaire peut entraîner une anémie sévère, des infections et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des radiations, des produits chimiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de maladies de la moelle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de maladies de la moelle."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/04/2025
Contenu vérifié selon les dernières recommandations médicales
└─
Aplasies médullaires
Bone Marrow Failure Disorders
D000080983
-
C15.378.190.223
└─
Maladies myélodysplasiques-myéloprolifératives
Myelodysplastic-Myeloproliferative Diseases
D054437
-
C15.378.190.615
└─
Syndromes myélodysplasiques
Myelodysplastic Syndromes
D009190
-
C15.378.190.625
└─
Syndromes myéloprolifératifs
Myeloproliferative Disorders
D009196
-
C15.378.190.636
└─└─
Anémie aplasique
Anemia, Aplastic
D000741
-
C15.378.190.223.250
└─└─
Leucémie myélomonocytaire juvénile
Leukemia, Myelomonocytic, Juvenile
D054429
-
C15.378.190.615.520
└─└─
Anémie réfractaire
Anemia, Refractory
D000753
-
C15.378.190.625.062
└─└─
Anémie sidéroblastique
Anemia, Sideroblastic
D000756
-
C15.378.190.625.070
└─└─
Hémoglobinurie paroxystique
Hemoglobinuria, Paroxysmal
D006457
-
C15.378.190.625.460
└─└─
Anémie myélophtisique
Anemia, Myelophthisic
D000750
-
C15.378.190.636.085
└─└─
Leucémie érythroblastique aigüe
Leukemia, Erythroblastic, Acute
D004915
-
C15.378.190.636.276
└─└─
Myélofibrose primitive
Primary Myelofibrosis
D055728
-
C15.378.190.636.765
└─└─
Thrombocytose
Thrombocytosis
D013922
-
C15.378.190.636.860
└─└─└─
Anémie réfractaire avec excès de blastes
Anemia, Refractory, with Excess of Blasts
D000754
-
C15.378.190.625.062.080
2 publications dans cette catégorie
Affiliations :
Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).
National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany (I.M.).
First Department of Internal Medicine, Department of Haematology and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece (I.M.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).
Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, United Kingdom (T.C.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Bone Vascular and Microcirculation Laboratory, Department of Kinesiology, University of Texas at Arlington, Arlington, Texas, USA.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic Rochester, MN, USA.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Te Toka Tumai Auckland (Auckland District Health Board), Grafton, Auckland, New Zealand.
Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Department of Radiology, IMSKE, València, Spain.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Institute of Clinical Sciences, Imperial College London, London, UK.
MRC London Institute of Medical Sciences, Imperial College London, London, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Institute of Clinical Sciences, Imperial College London, London, UK.
MRC London Institute of Medical Sciences, Imperial College London, London, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, Copenhagen Ø DK-2100, Denmark; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Mellanby Centre for Bone Research, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Electronic address: marta.castillo@sund.ku.dk.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Sheffield Myeloma Research Team, Department of Oncology and Metabolism, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Mellanby Centre for Bone Research, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.
Publications dans "Maladies de la moelle osseuse" :
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is partic...
We are pleased to present this Special Issue of the...
Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation...
A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal vali...
Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.7...
The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas....
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
The objective of this study was to assess the performance of ultrasound and magnetic resonance imaging (MRI) features in helping to classify the type of placenta accreta spectrum (PAS; accreta/increta...
We conducted a retrospective study in 82 pregnant women with PAS who underwent ultrasound and MRI examination of the pelvis before delivery (from an initial cohort of 185 women with PAS). We estimated...
Among the 82 patients, 29 (35%) had placenta accreta/increta and 53 (65%) had placenta percreta. The best features to discriminate between placenta accreta/increta and placenta percreta with ultrasoun...
The nomogram we developed to predict the risk of placenta percreta among patients with PAS had good discriminative capabilities. This performance and its impact on maternal morbidity should be confirm...
Prolactin, a pituitary hormone that was discovered about 80 years ago and is primarily known for its functions in mammary gland development and lactation, is now known to participate in numerous funct...
Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated t...
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....